Darmiyan
About Darmiyan
Darmiyan is a healthcare AI company that develops advanced brain imaging technology for the early detection, monitoring, and stratification of neurodegenerative disorders, particularly Alzheimer’s disease. Their flagship product, BrainSee, is an FDA-authorized, AI-powered clinical tool that utilizes standard clinical brain MRI scans and basic cognitive test results to generate detailed brain maps and scores. These outputs are designed to indicate pathology at the earliest stages, even before significant symptoms manifest.
For physicians, BrainSee offers a non-invasive and accurate method to assess a patient’s cognitive health and predict potential disease progression. This capability is crucial for providing timely and personalized treatment plans, potentially delaying the onset of dementia or mitigating symptom worsening in high-risk individuals. The technology leverages over four decades of neuroscience research and advanced medical image processing with machine learning/AI to quantify cellular-level changes within brain MRI scans, aiming to revolutionize the diagnostic and therapeutic landscapes for brain health.
Focus Areas
Business Intelligence
| Technology | AI-powered virtual microscope (BrainSee) that analyzes standard clinical brain MRIs and cognitive test results. |
What Physicians Need to Know
For physicians, Darmiyan's BrainSee offers a crucial tool for proactive patient management. It provides an objective, non-invasive, and highly accurate method to predict Alzheimer's progression in patients with MCI, enabling earlier intervention and personalized treatment plans. This can help differentiate between stable MCI patients and those likely to progress, avoiding unnecessary treatments and anxiety. The seamless integration with standard MRI and cognitive testing makes it easy to incorporate into existing clinical workflows. Furthermore, the detailed degeneration maps can offer valuable insights into focal areas of degeneration.
Darmiyan's BrainSee integrates standard brain MRI data with basic cognitive testing, age, and sex to generate its prognostic scores. This means it can be readily integrated into clinical practices that already utilize MRI scans and cognitive assessments. They aim for seamless integration and high accessibility globally.
What the Web Says
Darmiyan is a company focused on AI-powered brain health solutions, particularly for early detection of Alzheimer's disease. Reviews indicate a strong scientific foundation and innovative technology, but also highlight challenges common to startups, such as work-life balance and internal communication. The product, BrainSee, is generally viewed positively for its potential impact.
Overall: MixedStrengths
- Innovative AI technology for early Alzheimer's detection (BrainSee)
- Strong scientific and research-driven approach
- Potential to significantly impact healthcare and patient outcomes
- Dedicated and passionate team members
- Cutting-edge technology and product development
- Positive mission and vision
Limitations
- Work-life balance can be challenging due to startup environment
- Communication and management structure can be inconsistent
- High pressure and demanding work environment
- Compensation might not always be competitive with larger tech companies
- Limited publicly available detailed product reviews from end-users (patients/clinicians)
- Rapid growth can lead to organizational growing pains
Based on reviews from: Glassdoor, G2, Capterra, Reddit, Healthcare IT News, Company Website/Press Releases
Last updated: 2026-10-22
Videos
News, demos, and interviews about Darmiyan.
Videos load interactively. If none appear, search YouTube for Darmiyan →
Press & Coverage
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]